Jun Chen
Chief Commercial OfficerDr. Jun Chen, also known as Jack, Ph.D. serves as Chief Commercial Officer at VISEN Pharmaceuticals (Shanghai) Co., Ltd. since April 01, 2021. He has been Chief Commercial Officer at VISEN Pharmaceuticals since April 01, 2021. He served as Senior Director of Chemical Development (US) and Vice President of Asymchem Life Science at Asymchem Laboratories, Inc. Dr. Chen oversees cGMP R&D and production, API crystalization development and client technical interface. Since joining Asymchem in 2006, Dr. Chen has brought extensive knowledge and expertise in cGMP management. He has 10-year experience in pharmaceutical industry enhanced the development of Asymchem's innnovative R&D, process technology and product manufacturing. Dr. Chen previously served as researcher at the Shanghai Institute of Organic Chemistry and Eisai Research Institute at Boston. Dr. Chen has served as vice president of diabetes portfolio business unit at Eli Lilly China from July 2018 to March 2021. From May 2016 to July 2018, he was vice president of diabetes business group of Medtronic in greater China. From January 2002 to April 2016, Dr. Chen served at various management roles at Novo Nordisk USA and China where his final position was vice president of marketing at Novo Nordisk China from October 2010 to April 2016. He was an associate at McKinsey & Company from 2000 to 2002. Prior to that, Dr. Chen was pharmaceutical scientist at Merck & Co. and its affiliate company Merial Ltd. from 1997 to 2000. Dr. Chen served as a Senior Scientist at Pharmacia-Pfizer from 1998 to 2003 and a Team Manager at GSK from 2003 to 2005. Dr. Chen received his Bachelor’s degree in molecular biology from the University of Science and Technology of China in July 1992 and his Ph.D. degree from Purdue University in the U.S. in May 1997.
Positions
- Company NameVISEN PharmaceuticalsStock Code02561PositionChief Commercial Officer
